Science And Technology Board 1St Anniversary "Report Card": 111 Enterprises Have Won 1 Trillion And 770 Billion Of The Market Value, The Soviet Union Monopolized 20% Leads.

From the opening ceremony of the Eleventh Lujiazui forum in June 13, 2019, the official board was officially opened, and by June 17, 2020, the science and technology board had been running for a full year.

As a test field for China's capital market reform, what kind of "report card" has been handed over since the operation of the science and technology board?

Wind data show that as of June 17th, a total of 111 listed companies were listed, and the total initial capital raised was 129 billion 266 million yuan, with a total market value exceeding 1 trillion and 770 billion.

To provide experience for the full implementation of the registration system, the science and technology board also created many "first" in the history of A shares: "red chips first share" Huarun micro (688396.SH) landed in the science and create board; "the same share is not the same power first share". -W (688158.SH) was born. The first unprofitable enterprise, zhe pharmaceutical -U (688266.SH), became a member of the science and innovation board; A shares "the first CDR enterprise" robot No. nine passed smoothly, and also became a milestone in the operation of the science and technology board.

In addition, the major asset restructuring of the science and technology board is "breaking the ice". As of now, the reorganization of Huaxing yuan has been submitted for registration. It has been accepted from the reorganization application for only about 60 days. Zhou Ronghua, chief economist of Min CHUANG Group, thinks that this fully reflects the "core creation board speed" and the marketization core content of registration system.

Jiangsu, Zhejiang and Shanghai occupy half of the country

What are the characteristics of these 111 listed companies?

In twenty-first Century, according to the Wind data, according to the data of the twenty-first Century economic report, as of June 17th, 22 of the 111 listed companies were listed in Jiangsu, accounting for 19.8%. Apart from Jiangsu, Beijing and Guangdong respectively accounted for 19 listed companies, accounting for 17.1%.

In addition, Shanghai and Zhejiang were also unwilling to lag behind, contributing 16 and 11 science and Technology Board companies respectively. The total number of three listed companies in the Jiangsu, Zhejiang and Shanghai provinces was 49, accounting for 44%.

In addition, Hunan, Fujian and Shandong each have 4 board companies, 3 in Shaanxi, 2 in Tianjin, Hubei and Liaoning, and 1 in Heilongjiang, Henan and Sichuan.

Jin Jing, an analyst with China Merchants Securities, believes that as one of the most active and resource intensive regions in China's national innovation activities, the Yangtze River Delta and the Chuang Chuang board can be regarded as "a perfect match".

From the perspective of industry distribution, the 111 companies are mainly concentrated in the two major industries of information technology and health care (48 information technology and 24 medical care). In addition, the industry accounts for more than 10% of the industries and two industries of industry and materials, 18 for Industry and 11 for materials.

This is in line with the science and technology innovation enterprise, which is mainly in line with the national strategy, breaking through the key core technology, and highly recognized by the market, and especially encourages the five leading enterprises of the new generation of information technology, high-end equipment manufacturing, new materials, new energy, energy saving, environmental protection, biological medicine and technical services. For example, Zhongke star and Zhonglian data are engaged in Internet and cloud computing, big data services, rainbow soft technology and Haitian Rui. They are mainly AI, and the 5G industry such as voice holding, Weisheng information, Amethyst storage and so on.

In terms of total market capitalization, the total market capitalization of 111 companies has reached 1 trillion and 770 billion. The top three of the total market capitalization are Jinshan Office (688111.SH), 688012.SH and 688008.SH. As of June 17th, the market value of A shares was 120 billion 782 million yuan, 104 billion 416 million yuan and 96 billion 452 million yuan respectively.

In addition, the Shanghai silicon industry -U (688126.SH), Huaxi Biology (688363.SH), China general number (688009.SH), voice control (688036.SH) and other 4 science and Innovation Board enterprises are ranked 50 billion yuan total market value "club".

Which companies have become the "dark horse" in the market?

Judging from the ups and downs of the first day of listing, a total of 8 science and Technology Board companies rose more than 100%, namely 688399.SH, 688023.SH, Shanghai silicon industry -U, Bai Ren medical (688198.SH), China micro company, Orford environmental protection (688021.SH), Sanyou medical treatment (688085.SH) and Jinshan Office. Among them, Shuo Shi biological group won the championship by 320% interval. Information also ranked the 233% runner up, and the -U of the Shanghai silicon industry rose by 176%.

In December 5, 2019, Shuo Shi landed in the science and technology board, focusing on R & D, production and sales of in vitro diagnostic reagents, matching testing instruments and other diagnostic products, and expanded to the field of external detection services.

Affected by the epidemic, the sales volume of bio detection reagents increased significantly, and the revenue in the first quarter was 200 million yuan, an increase of 276.21% compared with the same period last year. Net profit was 104 million yuan, exceeding the full year profit in 2019, an increase of 670.91% over the same period last year. And its share price also hit a new high of 230.8 yuan / share.

Similar to that of Shuo Shi, with the closing price in June 17th (pre reinstated), the Ke Chuang plate contributed 19 shares to A shares, such as stone technology (688169.SH), Xin Mai medical treatment, and Anji technology, and accounted for nearly 1/4 of all A shares and 81 stocks in 3865 shares.

A shares many "first" in history

CAITONG Fund pointed out that the "5+2" listing standard set up by the science and technology board, introduced multiple indicators and opened the profit threshold. The breakthroughs in the listing threshold made the stocks of the science and technology board more inclusive, and were born with multiple "first" ones, such as "the first share of the same shares, the first share", "the first stock of red chips", "the first high priced stock" and the A CDR "first CDR enterprise".

In 2018, when the group became the first share of the Hong Kong stock "the same rights and different rights" (special voting rights), in January 20, 2020, the special voting rights structure was carved into the A board, marking the official "breaking the ice" with the different rights of the same stock.

In April 2019, the main public cloud and hybrid cloud business was launched from the entry and exit board, and from the inquiry to the final meeting, it experienced the four round of inquiries from the Shanghai Stock Exchange. In the final rounds of several rounds of inquiries before the summit, the protection of investors involved in the "right sharing of shares" has been highlighted by the Shanghai Stock Exchange.

Three days later, in January 23, 2020, zhe pharmaceutical successfully landed on the board of science and technology, becoming the first unprofitable business of the company, and also pioneered the unprofitable listing of A shares.

Zhe pharmaceutical is the first enterprise to choose fifth sets of listing standards in the company. Because the fifth set of listing standards do not involve performance standards, they are regarded as a space for unprofitable innovative biomedical enterprises.

Zhe pharmaceutical, founded in 2009, is an innovation driven new drug research and development enterprise focusing on many fields of treatment, such as cancer, hemorrhage and blood diseases, liver and gallbladder diseases. In June 2019, zhe pharmaceutical submitted the prospectus for its listing. Limited by capital expenditure for innovative research and development, it has not been profitable in the last three years as of the prospectus day.

"This opens the door to bio medical enterprises that need R & D investment and innovative technology, and also reflects the original intention of the science and technology board to encourage Biopharmaceutical Enterprises". In June 17th, a Shanghai brokerage firm commented on this.

In February 21, 2020, stone technology officially entered the science and technology board at the issuing price of 271.12 yuan / share, and was awarded the title of "the first high priced stock" in the issuing price set by the company.

As of June 17th closing, stone science and technology newspaper 373.8 yuan / share, is still the leader of the 111 science and technology innovation board; in all 3865 A shares, stone technology shares ranked fifth on the day, only lower than Guizhou Moutai (1405 yuan / share), Zhuo Sheng micro (576.84 yuan / share), Gigabit (449.3 yuan / share), Changchun high and new (375.9 yuan / share).

In February 27, 2020, Huarun micro, which appeared in the science and technology innovation board, broke the blank situation of A share market red chip enterprises with "red chips first stock".

Similarly, the "first" also has SMIC because of the speed of "lightning".

In June 1st, the listing of Hong Kong chips, which had been listed overseas, was accepted by the SMIC application board. In June 4th, it received inquiries. It responded in June 7th. It was announced in June 10th on June 19th. In just a week, it completed the first round of inquiry with the speed of "lightning". From the application to the meeting will only take 19 days to refresh the fastest record on the science creation board.

Financing is expected to break 100 billion in 2020.

In June 16th, DDT China released the latest report, "mainland China and Hongkong IPO Market Review and outlook for the first half of 2020", which was driven by the issuance of new stock issue by the stock exchange. The Shanghai Stock Exchange won 110 billion 500 million yuan in the first half of 2020 with 72 IPO financing of 110 billion 500 million yuan. HKEx raised HK $87 billion 100 million in the first half of this year, becoming the global IPO third in the first half of this year. Secondly, the NASDAQ issued 46 new shares in the first half of the year, with a financing amount of HK $109 billion.

DDT China pointed out that the first 5 major IPO in the first half of this year were Beijing-Shanghai high-speed railway, stone technology, Huarun micro, bulls group and Zhongtai securities, with financing amount of 30 billion 700 million yuan, 4 billion 500 million yuan, 3 billion 800 million yuan, 3 billion 600 million yuan and 3 billion yuan respectively.

In addition, DDT China expects to have a total of 100 -120 companies landing this year, and the total amount of financing will reach 110 billion yuan -1300 billion yuan, while the motherboard, small and medium sized boards and gem will estimate about 130-160 new shares throughout the year, with financing of about 170 billion yuan and -2200 billion yuan.

For the development of the science and technology board, Zhao Haizhou, a partner of China's A share capital market in East China, said: "we can see that the rapid growth of Shenzhen science and technology board and the amount of its financing exceeds the total value of the two plates in Shenzhen." Now, it has become a new hub for many innovative and new economic enterprises, especially in technology, media and telecommunications, medical and pharmaceutical industries. We also look forward to the formal implementation of the registration system reform of the gem, and push the mainland capital market to another round of transformation.

?